XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
Hangzhou Gaoxin Materials Technology
300478
Beijing Philisense Technology
300287
CN Stock MarketDetailed Quotes
601162 Tianfeng
- 4.84
- -0.17-3.39%
Market Closed Feb 14 15:00 CST
41.94BMarket Cap-64.53P/E (TTM)
4.91High4.75Low9.83MlotVolume4.83Open5.01Pre Close4.74BTurnover11.34%Turnover Ratio138.29P/E (Static)8.67BShares6.5052wk High1.82P/B41.94BFloat Cap2.1052wk Low5.51Limit Up8.67BShs Float10.44Historical High4.51Limit Down3.19%Amplitude2.10Historical Low--Dividend TTM4.82Avg Price4.43MlotAsk--Div YieldTTM100Lot Size4.99MlotBid
Tianfeng News
Tianfeng (601162.SH): The company has not connected to Doubao.
On February 14, GeLonghui reported that Tianfeng (601162.SH) stated on the interactive platform that the company has not connected to Doubao.
Tianfeng Securities (SHSE:601162) Shareholder Returns Have Been Decent, Earning 65% in 1 Year
Tianfeng: Maintains the Buy rating for Ideal Autos-W with a Target Price of 141.5 Hong Kong dollars.
Tianfeng Securities issued a research report stating that it maintains a "Buy" rating for Li Auto-W (02015). Considering the company's leading performance in Asia Vets and the new electric product lineup bringing a new growth cycle, a Target Price of HKD 141.5 is set. The firm forecasts the group's annual revenue for 2024 to 2026 to be 1, 47.6 billion, 2, 1.9 billion, and 2, 51.8 billion RMB, with Net income of 8.6 billion, 14.9 billion, and 18.6 billion RMB respectively. The report states that Li Auto's Asia Vets may redefine new luxury. With leading automakers beginning end-to-end PUSH and parking space to parking space, as well as L3.
Tianfeng: Initiates a "Shareholding" rating for STELLA HOLDINGS with a Target Price of 19.60 Hong Kong dollars.
Tianfeng released a Research Report stating that STELLA HOLDINGS (01836) has been given a “Shareholding” rating, corresponding to a Target Price of $2.52 (18.24 yuan, 19.60 HKD). It is expected that the company's revenue for 2024-2026 will be 1.62/1.76/1.92 billion USD (11.7/12.7/13.9 billion yuan), with net income for the parent company projected to be 0.17/0.19/0.21 billion USD (1.3/1.4/1.5 billion yuan), corresponding to a Target Market Cap of 2.1 billion USD (15 billion yuan). Tianfeng's main views are as follows: a global leading developer and manufacturer of footwear, with a long history of stable Operation and a high dividend payout.
Tianfeng Securities Issues Mixed Outlook for 2024; Shares Down 4%
Tianfeng Securities Co., Ltd. 2024 Annual Results Forecast
Sinophorus Offers 100 Million Shares in Shanghai IPO
Tianfeng: Maintaining SMOORE INTL's "Buy" rating and being bullish on the growth potential of the HNB new business.
Tianfeng released a research report stating that, based on the company's Technology and leading advantages, it maintains a "Buy" rating for SMOORE INTL (06969), expecting the company's Net income for 2024-2026 to be 1.609/1.966/2.494 billion yuan, with year-on-year changes of -2.19%/+22.19%/+26.85%. The firm believes that as a global leader in providing atomization Technology solutions, the company's barrier advantages are becoming more pronounced, and under the backdrop of increasingly stringent regulations, the concentration of the Industry Chain is expected to accelerate. Tianfeng's main points are as follows: the company released a revised announcement of the Stock-based Incentive plan, with performance objectives...
Tianfeng: Maintain KUAISHOU-W 'Buy' rating and suggest keeping an eye on the company's profit margin changes.
Tianfeng published a research report stating that, considering the advertising growth of KUAISHOU-W (01024) exceeds expectations, the company is projected to have revenues of 127.1/140.7 billion yuan for 2024-2025; the firm expects the company's adjusted net income for 2024-2025 to be 17.6/21.6 billion yuan, maintaining a "Buy" rating. In Q3 2024, the company achieved revenues of 31.1 billion yuan, with adjusted net income of 3.9 billion yuan and gross profit of 16.9 billion yuan. The firm believes the company's core business revenue is growing steadily and recommends continuous attention to changes in the company's profit margins. Tianfeng's main points are as follows: Flow
Tianfeng Securities Co., Ltd. (SHSE:601162) Stock Most Popular Amongst Retail Investors Who Own 59%, While Private Companies Hold 27%
Tianfeng: Maintain CTIHK's "Buy" rating, expected to become a direct beneficiary of Industry development and transformation.
Tianfeng released a research report stating that it maintains a "Buy" rating for CTIHK (06055), believing that the company, backed by the China Tobacco Group, has significant competitive advantages. It is currently the only overseas capital operation and international business expansion platform under China Tobacco, making it a rare entity and expected to become a direct beneficiary of the development and transformation of the Tobacco industry in China. The company forecasts its net income for 2024/25/26 to be 0.787/0.91/1.1 billion Hong Kong dollars; the company is the only international business platform within the China Tobacco system. The company issued a positive profit forecast, expecting that the profit attributable to owners for the full year of 2024 will increase by no less than 30% year-on-year.
Tianfeng Securities: Initiating coverage with a "Buy" rating for Chabaidao.
Recently, Tianfeng Securities initiated coverage on Cha Baidao (02555), assigning it a "Buy" rating. The report states that in terms of product capability, Cha Baidao's product matrix combines classic and seasonal limited products, leading the market with high cost performance; in terms of business model, the company's main source of income is from franchising, aiming for a more stable revenue source. Due to strict selection, only about 7% of candidates can become franchisees; in terms of supply chain, Cha Baidao continues to invest in supply chain construction. The firm expects that as supply chain efficiency improves and transportation costs are optimized, material costs will be effectively controlled, enhancing Cha Baidao's future gross profit.
Tianfeng: Maintains YUE YUEN IND ‘Buy’ rating with positive growth continuing in manufacturing in November.
Tianfeng released a research report stating that it maintains a "Buy" rating for YUE YUEN IND (00551), expecting the company's revenue for FY24-26 to be $8.65/9.65/10.94 billion, respectively; net profit attributable to parent company is expected to be $0.46/0.54/0.62 billion, respectively; and corresponding EPS is expected to be $0.28/0.33/0.38 per share, respectively. The company's revenue in November 2024 was $0.68 billion, a year-on-year increase of 7.5%, with cumulative revenue of $7.5 billion, a year-on-year increase of 3.4%. The main points from Tianfeng are as follows: The company released November data indicating that revenue from its manufacturing business in 2024 saw a year-on-year growth.
tianfeng Securities: Initiates Coverage on Kelun Botai Biomedical-B with a "shareholding" rating. Enhanced Commercialization Certainty.
Tianfeng released a research report stating that it has initiated coverage of Kelun Biotechnology-B (06990) with a "shareholding" rating. It forecasts the company's revenue for 2024-2026 to be 1.217 billion yuan, 1.654 billion yuan, and 2.476 billion yuan respectively; the net income attributable to the parent company is expected to be -0.72 billion yuan, -0.606 billion yuan, and -0.415 billion yuan. Considering the company's advantages in the ADC technology platform, substantial market space for core products, and promising overseas prospects, the company is viewed as bullish for development. The main viewpoints from Tianfeng are as follows: the ADC self-research capabilities are outstanding, with global research being advanced by Merck, and the certainty of commercialization is strengthened.
Tianfeng Securities: Ideal autos - W3-4Q fundamentals are gradually trending upwards with the expectation of recovery. The continuous improvement of store and infrastructure layout.
Tianfeng Securities released a research report stating that the bank believes that extreme emotions of concern about domestic consumption at the trade level have been digested in Q3. In fact, auto consumption saw a slight recovery in July driven by the policies of replacing old cars with new ones. The continuity of market demand thereafter is indeed difficult to determine, but the underlying fundamentals of Ideal Auto-W (02015) are expected to gradually improve in 3-4Q, and the bank predicts that the development of smart driving technology is expected to drive growth in vehicle value/gross margin.
Tianfeng Securities: Maintains a "buy" rating on China Longyuan, with asset injection helping to boost installed capacity growth.
Tianfeng Securities issued a research report stating that it maintains a 'buy' rating on China Longyuan (00916), with forecasted net income attributable to the parent company in 2024-2026 of 6.6, 7.5, and 8.2 billion yuan. The company announced its performance for the third quarter of 2024. In the first three quarters, the company achieved a revenue of 26.35 billion yuan, a year-on-year decrease of 6.37%; and a net income attributable to the parent company of 5.668 billion yuan, a year-on-year decrease of 11.38%. The main points from Tianfeng Securities are as follows: the equity of Jiangyin Sulong has been transferred, with a year-on-year increase of 2.4% in power generation for the first three quarters. The equity of Jiangyin Sulong Thermoelectric Co., Ltd. has been transferred, reducing the controlled installed capacity by 1.24 GW.
msci chinese index adjustment announced! 4 new constituent stocks including Chuantou Energy (601136.SH)
On November 7th, the international index compilation company MSCI announced the index quarterly adjustment results for November 2024, which will take effect after the market closes on November 25, 2024.
tianfeng Securities (601162.SH): The company has no assets restructuring plan.
GE Longhui November 6th, tianfeng Securities (601162.SH) stated on the interactive platform that the company has no asset restructuring plan or other significant matters that should be disclosed but have not been disclosed.
Tianfeng Securities (601162.SH): The company does not have a localized debt business for AMC.
November 5, Geelonghui | Tianfeng Securities (601162.SH) stated on the interactive platform that the company does not have localized AMC debt business. Details of the company's main business can be found in the company's disclosed quarterly reports.
Tianfeng Securities: Tianfeng Securities Co., Ltd. Report for the Third Quarter of 2024